The psoriasis decision tree

George Monks, Ryan Rivera-Oyola, Mark Lebwohl

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Psoriasis, an inflammatory disorder of the skin, is associated with an increased risk of systemic diseases, such as psoriatic arthritis, psychiatric disorders, malignancy, and cardiometabolic and inflammatory bowel diseases. Careful consideration of the presence of these comorbidities should guide selection of appropriate therapy. The evolution of therapeutic targets for the treatment of psoriasis has significantly advanced available treatment options, potentially leading to uncertainty when selecting the optimal treatment for each patient. In this article, we review evidence-based guidelines for the use of psoriasis treatments in patients with distinct comorbidities, and group appropriate therapeutic options into a visual aid. An easy-to-use visual tool incorporating treatment options best suited for specific comorbidities can increase physicians' confidence when selecting the most appropriate treatment on an individualized basis.

Original languageEnglish
Pages (from-to)14-22
Number of pages9
JournalJournal of Clinical and Aesthetic Dermatology
Volume14
Issue number4
StatePublished - 1 Apr 2021

Keywords

  • Acitretin
  • Biologics
  • Brodalumab
  • Comorbidities
  • Cyclosporine
  • Depression
  • Guselkumab
  • Inflammatory bowel disease
  • Ixekizumab
  • Kidney disease
  • Liver disease
  • Methotrexate
  • Multiple sclerosis
  • Pregnancy
  • Psoriasis
  • Psoriatic arthritis
  • Risankizumab
  • Secukinumab
  • Tildrakizumab
  • Ustekinumab

Fingerprint

Dive into the research topics of 'The psoriasis decision tree'. Together they form a unique fingerprint.

Cite this